Shell Stocks; Reverse Mergers; Acquisitions; Zombies; Greys; & All "Other" Plays

[Potse]

GSAC(.0035)...cannabis-sector play......

I accumulated shares of GSAC in the .003-.0035 range last week. GSAC acquired ownership of Mastix Medica about two years ago (and in the process gained exposure to the cannabis sector). GSAC is involved in the research/development, formulation, manufacturing, and marketing of over-the-counter healthcare products (gum, tablets, lozenges, mints, candies, etc.). The company has a patent-pending manufacturing process for incorporating hemp-oil into gums and tablets.

Its a very high-risk investment, but the stock looks relatively attractive given its under-followed nature and the current market interest for sub-penny cannabis plays.

Although it is about a year old, the GSAC Executive Summary from November 2015 provides a nice amount of information about the company and its plans it had heading into year 2016. Included in the summary is info on its cannabis-related activity (products, clinical studies, etc.) and some financial/business information regarding potential products in the pipeline.

Also from the summary.....

In addition to the aforementioned opportunities Mastix is working on multiple projects with approximately 20 potential customers to develop products including CBD gum and lozenges, energy products, tobacco gum, weight loss gum, cough lozenge, lozenge for nausea, chewable for eye health, gum with an anti-inflammatory active, and a chewable antacid.

http://content.equisolve.net/gelstat2/media/b96257095f461068f4fbc23e42caff67.pdf

GelStat website....

http://www.gelstat.com/

Mastix Medica website....

http://mastixmedica.com/hemp-oilcbd/